Blog

[CASE STUDY] Efficacy and safety of a nasal spray versus placebo in the treatment of early symptoms of common cold in adults

Key informationMain study endpoints- Change from baseline in the relief of nasal congestion - Common cold symptoms- Quality of life interfered with common coldPopulation144 subjects presenting with early symptoms of common coldTested productMedical...

[NEWS] ACCELERATE YOUR ASSAYS

In a continuous improvement of our performance and analytical capabilities that's complements Biofortis Central lab, our expert staff members have worked to implement a new machine: LUMINEX LX-200. LUMINEX LX-200 system is a compact analyser that performs up to 100...

[CASE STUDY] Randomized, placebo-controlled, double-blinded study to evaluate the effect of probiotics on gut function in healthy Chinese adults

Key informationMain study endpoints- Number of bowel movements - Bowel habits - Stool consistency - Severity of bloating and abdominal discomfortPopulation200 healthy subjects having ≥ 3 Bowel Movements per dayTested productDietary supplementInvestigations1 site in...

[CASE STUDY] Randomized, placebo-controlled, double-blinded study of the effect of plant extracts on glucose and lipid homeostasis in subjects with dysglycemia

Key informationMain study endpoints- Glycemia - Lipid and glucose profile/homeostasia - DEXAPopulation636 prediabetes patientsTested productPlant extractsInvestigations53 sites in 7 countries : France, Germany, Italy, Bulgaria, Hungary, Poland and RomaniaKey...

[CASE STUDY] Pharma clinical study in patients treated for cancer

Jul 26, 2023 | Case studies_Central Lab

Key informationObjectiveAnalysis of safety parameters and biomarkers of intestinal microbiotaStudy design-...

[CASE STUDY] Sample collection in Oncology

Jul 26, 2023 | Case studies_Central Lab

Key informationObjectiveAnalysis of intestinal microbiotaStudy design- Multicentre, in France- A nine-year-long...

[CASE STUDY] Pharma clinical study on cardiac pathology

Jul 26, 2023 | Case studies_Central Lab

Key informationObjectiveAnalysis of cardiac biomarkersStudy design- International multicentric: Europe, Australia,...

[ARTICLE] Long chain unsaturated fat is cytotoxic for cancer cells

Dec 22, 2022 | Health

Killing tumour cells by fatty indigestion: here is the strategy to fight cancer, explored by Belgian scientists from Louvain University. Their work, recently published in Cell Metabolism(1),...

[NEWS] Welcome aboard Morgan and Fanny!

Nov 9, 2022 | News

We are pleased to welcome Morgan Cabigliera, as Head of the Sales & Marketing Business Unit and Fanny Doistau, as Clinical Business Unit Director, as part of the Biofortis team. Morgan has a...

[ARTICLE] Microbes in semen…

Nov 2, 2022 | Microbiome

It is quite well-known nowadays that our body cavities such as the gut, mouth, nose, lungs, vagina, or our skin surface, shelter millions of micro-organisms: these communities are called...

[Le French Gut] – Biofortis is part of the national project Le French Gut, to accelerate the science of the microbiota

Sep 15, 2022 | News

Biofortis as a unique full service CRO providing Nutrition Clinical Trials, Microbiome Investigation and Data Science for Human and Animal Health is part of Le French Gut project. Le French Gut...

[ARTICLE] Diet supplementation with the probiotic Saccharomyces cerevisiae helps alleviate abdominal pain of IBS patients.

Jun 28, 2022 | Microbiome

IBS is a 3-letter acronym that strongly impacts the lives of millions of people worldwide. It stands for irritable bowel syndrome, a complex condition that exhibits various forms, depending on the...

[EVENT] Global Engage Microbiome & Probiotic R&D & Business Collaboration Forum: Europe

May 17, 2022 | News

May 24th and 25th, 2022We are pleased to meet you again during Global Engage - May 24th/25th in the Netherlands. Our team will remain at your disposal to discuss with you about Microbiome Projects...